Putty Version Of BonAlive Bioactive Bone Regenerator Launched
Following the receipt of CE mark approval, BonAlive Biomaterials has launched a patented, ready-to-use and mouldable putty version of its osteostimulative BonAlive bioactive glass bone regeneration technology in Europe. The launch of BonAlive putty is an important milestone in the commercialisation strategy of the BonAlive product range. The current BonAlive granules products have been approved for orthopaedic use since 2006 and for bone cavity filling in the treatment of chronic osteomyelitis since March 2011. The company believes that BonAlive putty will significantly strengthen its position in the trauma and spine market as surgeons are increasingly demanding products that are both easy and ready to use, while delivering a solid clinical outcome.